FDAClass IJune 14, 2017

Magellan Diagnostics LeadCare Ultra and LeadCare Plus recall

Magellan Diagnostics LeadCare Ultra and LeadCare Plus test Kits. Product Usage: The LeadCare Blood Lead Test Kit is for in vitro diagnostic use only.…

Why was Magellan Diagnostics LeadCare Ultra and LeadCare Plus recalled?

Underestimates the lead concentration of venous blood samples when the sample is analyzed with the LeadCare systems

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

All lot codes

Product
Magellan Diagnostics LeadCare Ultra and LeadCare Plus test Kits. Product Usage: The LeadCare Blood Lead Test Kit is for in vitro diagnostic use only.…
Recalling firm
Magellan Diagnostics, Inc.
Quantity
6018 kits (total)= 5818 (US)and 200 (OUS)
Distribution
Worldwide Distribution - US (Nationwide) Foreign: AUSTRALIA AUSTRIA BOLIVIA CANADA CHILE CHINA COLOMBIA DOMINICAN REPUB ENGLAND GERMANY INDIA UK ISRAEL ITALY JAPAN KOREA MALI MYANMAR SPAIN NEPAL NETHERLANDS NEW ZEALAND P.R. CHINA PANAMA US PERU PHILLIPINES POLAND PORTUGAL REP OF KOSOVO SOUTH AFRICA SRI LANKA USA SWEDEN SWITZERLAND TRINIDAD UNITED ARAB EMI VIETNAM
Recall date
June 14, 2017
Classification
Class I
Status
Terminated
Agency
FDA (device)
Open FDA enforcement record Latest recalls